EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The efficacy of the analgesic GlyT2 inhibitor, ORG25543 , is determined by two connected allosteric sites

Ryan Cantwell Chater iD, Ada S Quinn iD, Katie Wilson iD, Zachary J Frangos, Patrick Sutton iD, Srinivasan Jayakumar, Christopher L Cioffi, Megan L O'Mara, Robert J Vandenberg iD

Journal of Neurochemistry · 2024

DOI: 10.1111/jnc.16028 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Neurochemistry, 2024. Verfasst von Ryan Cantwell Chater und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Medical Sciences, University of Sydney, Sydney, New South Wales, Australia. Hauptthemen laut MEDLINE: Glycine Plasma Membrane Transport Proteins, Analgesics, Allosteric Site. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDA NIH HHS, National Health and Medical Research Council, National Institute for Drug Abuse, USA.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glycine Transporter 2 (GlyT2) inhibitors have shown considerable potential as analgesics for the treatment of neuropathic pain but also display considerable side effects. One potential source of side effects is irreversible inhibition. In this study, we have characterized the mechanism of ORG25543 inhibition of GlyT2 by first considering three potential ligand binding sites on GlyT2—the substrate site, the vestibule allosteric site and the lipid allosteric site. The three sites were tested using a combination of molecular dynamics simulations and analysis of the inhibition of glycine transport of a series point mutated GlyT2 using electrophysiological methods. We demonstrate that the lipid allosteric site on GlyT2 is the most likely binding site for ORG25543. We also demonstrate that cholesterol derived from the cell membrane can form specific interactions with inhibitor‐bound transporters to form an allosteric network of regulatory sites. These observations will guide the future design of GlyT2 inhibitors with the objective of minimising on‐target side effects and improving the therapeutic window for the treatment of patients suffering from neuropathic pain. image

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Glycine Plasma Membrane Transport ProteinsAnalgesicsAllosteric SiteHumansAnimalsMolecular Dynamics SimulationBinding SitesGlycineBenzamides

Stichwörter der Autor:innen

allosteric inhibitionanalgesiccholesterolglycine transportermolecular dynamicsneuropathic pain

Substanzen

Glycine Plasma Membrane Transport ProteinsAnalgesics4-benzyloxy-3,5-dimethoxy-N-(1-(dimethylaminocyclopently)methyl)benzamideSLC6A5 protein, humanGlycineBenzamides

Autor:innen und Institutionen

  • School of Medical Sciences, University of Sydney, Sydney, New South Wales, Australia.
  • Research School of Chemistry, College of Science, The Australian National University, Canberra, Australian Capital Territory, Australia.
  • Australian Institute of Bioengineering and Nanotechnology, The University of Queensland, St Lucia, Queensland, Australia.
  • Department of Chemistry and Chemical Biology, Rensselaer Polytechnic Institute, Troy, New York, USA.

ORCID-Profile: Ryan Cantwell Chater, Ada S Quinn, Katie Wilson, Patrick Sutton, Robert J Vandenberg

Förderung

  • NIDA NIH HHS
  • National Health and Medical Research Council
  • National Institute for Drug Abuse, USA

Zitieren

APA

Chater, R. C., Quinn, A. S., Wilson, K., Frangos, Z. J., Sutton, P., Jayakumar, S., Cioffi, C. L., O'Mara, M. L., & Vandenberg, R. J. (2024). The efficacy of the analgesic GlyT2 inhibitor, ORG25543 , is determined by two connected allosteric sites. Journal of Neurochemistry. https://doi.org/10.1111/jnc.16028

Vancouver

Chater RC, Quinn AS, Wilson K, Frangos ZJ, Sutton P, Jayakumar S, et al. The efficacy of the analgesic GlyT2 inhibitor, ORG25543 , is determined by two connected allosteric sites. Journal of Neurochemistry. 2024. doi:10.1111/jnc.16028

BibTeX
@article{Chater2024,
  author = {Chater, Ryan Cantwell and Quinn, Ada S and Wilson, Katie and Frangos, Zachary J and Sutton, Patrick and Jayakumar, Srinivasan and Cioffi, Christopher L and O'Mara, Megan L and Vandenberg, Robert J},
  title = {The efficacy of the analgesic GlyT2 inhibitor, ORG25543 , is determined by two connected allosteric sites},
  journal = {Journal of Neurochemistry},
  year = {2024},
  doi = {10.1111/jnc.16028}
}
Kostenlos starten →